Drug repurposing and discovery multidisciplinary training network

Project Information

DRUGtrain

Grant agreement ID: 955879

DOI 10.3030/955879

EC signature date 16 July 2020

Start date 1 January 2021

End date 31 December 2024

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost € 2 394 816,84

EU contribution € 2 394 816,84

Coordinated by

ACADEMISCH ZIEKENHUIS LEIDEN
Netherlands

Deliverables

Other (4)

Presentations and publications

Presentations at international meetings and articles for peer review journals and/or theses.The reporting period of this deliverable will cover the period from mo 12 to mo 48.

Network meetings - dissemination

Organisation of dissemination session at network meetings.The reporting period of this deliverable will cover the period from mo 10 to mo 46.

Dissemination, communication and IP activities

Reporting on dissemination, communication and IP activities.The reporting period of this deliverable will cover the period from mo 12 to mo 48.

Presentation/activities at open days, student fairs, (social) media

Presentation/activities at open days, student fairs, (social) media.The reporting period of this deliverable will cover the period from mo 6 to mo 46.

Websites, patent fillings, videos etc. (1)

Launch of DRUGtrain website and twitter account

Launch of DRUGtrain website and twitter account established

Documents, reports (1)

Patient derived 3D organoid culture

Report on patient derived 3D organoid culture

Publications

Peer reviewed articles (1)

Label-free but still constrained: Assessment of global proteomic strategies for the quantification of hepatic enzymes and transporters

Author(s): Barber J, Al-Majdoub ZM, Couto N, Vasilogianni AM, Tillmann A, Alrubia S, Rostami-Hodjegan A, Achour B.
Published in: Drug metabolism and disposition, Issue 50, 2022, Page(s) 762-769, ISSN 0090-9556
Publisher: American Society for Pharmacology and Experimental Therapeutics
DOI: 10.1124/dmd.121.000780